Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE SABRINA MENIAOUI-KERRACHE : revenue, balance sheet and financial ratios

PHARMACIE SABRINA MENIAOUI-KERRACHE is a French company founded 3 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NARBONNE (11100), this company of category PME shows in 2024 a net income positive of 55 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE SABRINA MENIAOUI-KERRACHE (SIREN 917653990)
Indicator 2024 2023
Revenue N/C N/C
Net income 54 816 € 21 293 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2024, PHARMACIE SABRINA MENIAOUI-KERRACHE generates positive net income of 55 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 21 k€ -> 55 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

54 816 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 828%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

828.167%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

9.723%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

0.7%

Solvency indicators evolution
PHARMACIE SABRINA MENIAOUI-KERRACHE

Sector positioning

Debt ratio
828.17 2024
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of PHARMACIE SABRINA MENIAOU... (828.17) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
9.72% 2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of PHARMACIE SABRINA MENIAOU... (9.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 292.90. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

292.905

Liquidity indicators evolution
PHARMACIE SABRINA MENIAOUI-KERRACHE

Sector positioning

Liquidity ratio
292.9 2024
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent +24 pts over 2 years

In 2024, the liquidity ratio of PHARMACIE SABRINA MENIAOU... (292.90) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE SABRINA MENIAOUI-KERRACHE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE SABRINA MENIAOUI-KERRACHE is estimated at 765 271 € (range 532 923€ - 1 144 890€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
532k€ 765k€ 1144k€
765 271 € Range: 532 923€ - 1 144 890€
NAF 5 année 2024

Valuation method used

Net Income Multiple
54 816 € × 14.0x = 765 272 €
Range: 532 923€ - 1 144 891€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE SABRINA MENIAOUI-KERRACHE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE SABRINA MENIAOUI-KERRACHE

What is the revenue of PHARMACIE SABRINA MENIAOUI-KERRACHE ?

The revenue of PHARMACIE SABRINA MENIAOUI-KERRACHE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE SABRINA MENIAOUI-KERRACHE profitable?

Yes, PHARMACIE SABRINA MENIAOUI-KERRACHE generated a net profit of 55 k€ in 2024.

Where is the headquarters of PHARMACIE SABRINA MENIAOUI-KERRACHE ?

The headquarters of PHARMACIE SABRINA MENIAOUI-KERRACHE is located in NARBONNE (11100), in the department Aude.

Where to find the tax return of PHARMACIE SABRINA MENIAOUI-KERRACHE ?

The tax return of PHARMACIE SABRINA MENIAOUI-KERRACHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE SABRINA MENIAOUI-KERRACHE operate?

PHARMACIE SABRINA MENIAOUI-KERRACHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.